首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells.
【24h】

Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells.

机译:草药Sho-saiko-to(TJ-9)对培养的大鼠肝星状细胞中细胞增殖和前胶原基因表达的抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: It is of extreme importance to prevent liver fibrosis and subsequent progression to liver cirrhosis. The aim of our study was to elucidate in vitro whether Sho-saiko-to exerted inhibitory effects on hepatic stellate cells. METHODS: Hepatic stellate cells were isolated from male Wistar rats. Water-soluble ingredients of Sho-saiko-to were obtained at concentrations of 10, 100, 250, 500 and 1000 microg/ml. Morphological transformation was observed under a phase-contrast microscope. Flow cytometric analysis was performed on day 4 after culture to evaluate the potential to proliferate of the stellate cells by analyzing cell cycles. Northern blot analysis was carried out on day 3 after culture to determine the expressions of type I and type III procollagen mRNAs. RESULTS: (i) Sho-saiko-to 500 and 1000 microg/ml inhibited morphological transformation of the stellate cells to myofibroblast-like cells. (ii) Sho-saiko-to 500 and 1000 microg/ml significantly (p<0.0001) accumulated the cells in the G0/G1 phase (118.8+/-0.7%, 119.2+/-0.5%, respectively as compared with control) and significantly (p<0.0001) decreased cell numbers subsequently in G2/M phase (47.5+/-8.1%, 48.9+/-2.0%, respectively). (iii) Sho-saiko-to 500 and 1000 microg/ml also significantly (p<0.05 or p<0.0001) suppressed procollagen mRNA expression of type I to 51.5+/-6.4%, 34.9+/-3.7%, respectively, and type III to 51.3+/-12.3%, 46.7+/-11.4%, respectively. CONCLUSIONS: We have clarified the inhibitory effects of Sho-saiko-to on hepatic stellate cells in vitro. Sho-saiko-to could be a potent inhibitor in the pathogenesis of liver fibrosis.
机译:背景/目的:预防肝纤维化和随后发展为肝硬化至关重要。我们研究的目的是在体外阐明Sho-saiko-to是否对肝星状细胞产生抑制作用。方法:从雄性Wistar大鼠中分离出肝星状细胞。获得的Sho-saiko-to水溶性成分的浓度为10、100、250、500和1000 microg / ml。在相差显微镜下观察到形态学转变。培养后第4天进行流式细胞仪分析,通过分析细胞周期来评估星状细胞增殖的潜力。培养后第3天进行RNA印迹分析以确定I型和III型前胶原mRNA的表达。结果:(i)Sho-saiko-to 500和1000 microg / ml抑制星状细胞向成肌纤维细胞样细胞的形态转化。 (ii)Sho-saiko-to 500和1000 microg / ml显着(p <0.0001)积聚了G0 / G1期的细胞(与对照组相比分别为118.8 +/- 0.7%,119.2 +/- 0.5%)随后在G2 / M期显着(p <0.0001)减少了细胞数量(分别为47.5 +/- 8.1%,48.9 +/- 2.0%)。 (iii)Sho-saiko-to 500和1000 microg / ml还显着(p <0.05或p <0.0001)将I型前胶原mRNA的表达分别抑制为51.5 +/- 6.4%,34.9 +/- 3.7%和III型分别为51.3 +/- 12.3%,46.7 +/- 11.4%。结论:我们已经阐明了Sho-saiko-to在体外对肝星状细胞的抑制作用。 Sho-saiko-to可能是肝纤维化发病机制的有效抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号